OTC Pharmaceuticals in Turkey

Date: September 27, 2016
Pages: 34
Price:
US$ 350.00
License [?]:
Publisher: MarketLine
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: OAACD9F7F08EN
Leaflet:

Download PDF Leaflet

OTC Pharmaceuticals in Turkey
SUMMARY

OTC Pharmaceuticals in Turkey industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

KEY FINDINGS
  • Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the otc pharmaceuticals market in Turkey
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the otc pharmaceuticals market in Turkey
  • Leading company profiles reveal details of key otc pharmaceuticals market players' global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the Turkey otc pharmaceuticals market with five year forecasts
SYNOPSIS

Essential resource for top-line data and analysis covering the Turkey otc pharmaceuticals market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

REASONS TO BUY
  • What was the size of the Turkey otc pharmaceuticals market by value in 2015?
  • What will be the size of the Turkey otc pharmaceuticals market in 2020?
  • What factors are affecting the strength of competition in the Turkey otc pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitors in Turkey's otc pharmaceuticals market?
KEY HIGHLIGHTS

The OTC pharmaceuticals market consists of the retail sale of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirin and other analgesics), medicated skin products (anti-bacterials, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters and bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, and motion sickness). The market is valued according to retail selling price (RSP) and includes any applicable taxes. Any currency conversions used in the creation of this report have been calculated using constant 2015 annual average exchange rates.

The Turkish OTC pharmaceuticals market generated total revenues of $1,133.1m in 2015, representing a CAGR of 6.4% between 2011 and 2015.

Analgesics registered the highest sales value in the Turkish OTC Pharmaceuticals market in 2015, with total sales of $296.1m, equivalent to 26.1% of the market's overall value.

Turkey's spending on healthcare was approximately 5.2% of GDP, way below the average of OECD, but represents a clear increase from 2.5% in 1990.
Executive Summary
Market value
Market value forecast
Category segmentation
Geography segmentation
Market share
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Category segmentation
Geography segmentation
Market share
Market distribution
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Abdi Ibrahim Ilac Sanayi ve Ticaret A.S.
GlaxoSmithKline Plc
Nobel Ilac San ve Tic A.S.
Novartis AG
Macroeconomic Indicators
Country data
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine

LIST OF TABLES

Table 1: Turkey OTC pharmaceuticals market value: $ million, 2011-15
Table 2: Turkey OTC pharmaceuticals market category segmentation: $ million, 2015
Table 3: Turkey OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 4: Turkey OTC pharmaceuticals market share: % share, by value, 2015
Table 5: Turkey OTC pharmaceuticals market distribution: % share, by value, 2015
Table 6: Turkey OTC pharmaceuticals market value forecast: $ million, 2015-20
Table 7: Abdi Ibrahim Ilac Sanayi ve Ticaret A.S.: key facts
Table 8: GlaxoSmithKline Plc: key facts
Table 9: GlaxoSmithKline Plc: key financials ($)
Table 10: GlaxoSmithKline Plc: key financials (£)
Table 11: GlaxoSmithKline Plc: key financial ratios
Table 12: Nobel Ilac San ve Tic A.S.: key facts
Table 13: Novartis AG: key facts
Table 14: Novartis AG: key financials ($)
Table 15: Novartis AG: key financial ratios
Table 16: Turkey size of population (million), 2011-15
Table 17: Turkey gdp (constant 2005 prices, $ billion), 2011-15
Table 18: Turkey gdp (current prices, $ billion), 2011-15
Table 19: Turkey inflation, 2011-15
Table 20: Turkey consumer price index (absolute), 2011-15
Table 21: Turkey exchange rate, 2011-15

LIST OF FIGURES

Figure 1: Turkey OTC pharmaceuticals market value: $ million, 2011-15
Figure 2: Turkey OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 3: Turkey OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 4: Turkey OTC pharmaceuticals market share: % share, by value, 2015
Figure 5: Turkey OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 6: Turkey OTC pharmaceuticals market value forecast: $ million, 2015-20
Figure 7: Forces driving competition in the OTC pharmaceuticals market in Turkey, 2015
Figure 8: Drivers of buyer power in the OTC pharmaceuticals market in Turkey, 2015
Figure 9: Drivers of supplier power in the OTC pharmaceuticals market in Turkey, 2015
Figure 10: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Turkey, 2015
Figure 11: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Turkey, 2015
Figure 12: Drivers of degree of rivalry in the OTC pharmaceuticals market in Turkey, 2015
Figure 13: GlaxoSmithKline Plc: revenues and profitability
Figure 14: GlaxoSmithKline Plc: assets and liabilities
Figure 15: Novartis AG: revenues and profitability
Figure 16: Novartis AG: assets and liabilities

COMPANIES MENTIONED

Abdi Ibrahim Ilac Sanayi ve Ticaret A.S.
GlaxoSmithKline Plc
Nobel Ilac San ve Tic A.S.
Novartis AG
Skip to top


Ask Your Question

OTC Pharmaceuticals in Turkey
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: